ICRA reaffirms CP/STD programme of Unichem Laboratories

16 Aug 2011 Evaluate

Credit rating agency, ICRA has reaffirmed the A1+ rating assigned to the Rs 15.0 crore Commercial Paper (CP) / Short Term Debt (STD) programme of Unichem Laboratories.

The rating reaffirmation takes into account the company’s established presence in the domestic formulation business with sizeable exposure towards the fast growing and relatively high margin chronic therapeutic segments.

Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and APIs. The company offers products in therapeutic areas like gastro-intestinal, cardiovascular, diabetes, psychiatry, neurology, anti-bacterial, anti-infective and pain management, among others.

Unichem Lab Share Price

444.55 -1.10 (-0.25%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×